Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Bear Of The Day: National Beverage Corp. (FIZZ)

Published 01/31/2020, 06:00 AM
Updated 07/09/2023, 06:31 AM

LaCroix maker National Beverage Corp. (FIZZ) has become a victim of its own success. The company’s sales had soared for years and its stock price came along for the ride, but its flagship flavored seltzer drink became so popular that Coca-Cola (KO), PepsiCo (NASDAQ:PEP) (PEP), and many others flooded the quickly expanding seltzer market.

Lost its Fizz?

National Beverage makes roughly 70% of its sales from LaCroix. The flavored seltzer brand, with multiple flavors, has been around for decades, but really kicked things into high gear over the last five-plus years as consumers searched for alternatives to sugary sodas.

LaCroix began to fly off shelves and helped create the current seltzer drink craze that has slipped over into the alcoholic beverage market, from Anheuser Busch Inbev (BR:ABI) NV (BUD) to Boston Beer (SAM).

National Beverage’s success saw PepsiCo launch its Bubly brand, while Coca-Cola bought Topo Chico in 2017. Coca-Cola is now set to launch its new sparkling water brand AHA in March.

Plus, retail giants such as Target (TGT) sell their own store brands and startups are popping up all the time. On top that, the company has been sued in a class-action lawsuit based on claims that its all-natural claims are false. National Beverage has denied the allegations.

In the end, the crowded market makes things harder on National Beverage, and some brands have undercut LaCroix on price. FIZZ still holds the largest market share, based on the most recent industry reports. However, the company’s sales have slipped against hard to compare periods.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Bottom Line

National Beverage’s sales have fallen over the last four quarters, and are down 4.2% in the trailing 12 months. The firm’s earnings have also fallen.

Looking ahead, our Zacks estimates call for the company’s sales to sink 5.1% in its current fiscal year and another 3.1% next year. Worse still, FIZZ is projected to see its adjusted earnings fall over 19% this year and nearly 8% during the next fiscal year.

The nearby chart shows investors just how far FIZZ shares have spilled, down 63% since the fall of 2018. Despite the downturn, National Beverage stock is still trading at 19.7X forward 12-months earnings estimates, which marks a premium compared to the S&P 500’s 18.8X and remains well above its year-long low of 11.7X.

National Beverage has also seen its earnings estimate revision activity trend in the wrong direction recently, which helps it hold a Zack Rank #5 (Strong Sell).

Investors still interested in the broader Beverages market might want to check out #2 (Buy)-ranked Monster Beverage Corporation (NASDAQ:MNST) (MNST) or Coca-Cola.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Target Corporation (NYSE:TGT

The Boston Beer Company, Inc. (SAM): Free Stock Analysis Report

PepsiCo, Inc. (PEP): Free Stock Analysis Report

Monster Beverage Corporation (MNST): Free Stock Analysis Report

Coca-Cola Company (The) (NYSE:KO

National Beverage Corp. (FIZZ): Free Stock Analysis Report

Anheuser-Busch InBev SA/NV (BUD): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.